STAAR Surgical Co 2024年度报告

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes☐No☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Actof 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject tosuch filing requirements for the past 90 days. Yes☑No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submitsuch files).Yes☑No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerginggrowth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of itsinternal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firmthat prepared or issued its audit report.☑ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant includedin the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensationreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☑ The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 28, 2024, the lastbusiness day of the registrant’s most recently completed second fiscal quarter, was approximately $2,340,566,448 based on the closing price per shareof $47.61 of the registrant’s Common Stock on that date. The registrant has 49,325,372 shares of common stock, par value $0.01 per share, issued and outstanding as of February 18, 2025. DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s definitive proxy statement relating to its 2025 annual meeting of stockholders, which will be filed with the Securitiesand Exchange Commission pursuant to Regulation 14A within 120 days of the close of the registrant’s last fiscal year, are incorporated by referenceinto Part III of this report. STAAR SURGICAL COMPANY TABLE OF CONTENTS PART I.............................................................................................................................................2ITEM 1.Business..............................................................................................................................2ITEM 1A.Risk Factors.......................................................................................................................17ITEM 1B.Unresolved Staff Comments.............................................................................................30ITEM 1C.Cybersecurity....................................................................................................................31ITEM 2.Properties...........................................................................................................................32ITEM 3.Legal Proceedings.............................................................................................................32ITEM 4.Mine Safety Disclosures....................................................................................................32PART II.............................................................................................................................................32ITEM 5.Market for Registrant’s Common Equity, Related Stockholder Matters, andIssuer Purchases of Equity Securities.............................................................................32ITEM 6.[Reserved]..........................................................................................................................33ITEM 7.Management’s Discussion and Analysis of Financial Condition and Results ofOperations.....................................................................